A new therapeutic avenue for Parkinson’s disease

Clearing senescent astrocytes prevents Parkinson’s in mouse model of sporadic disease. Systemic clearing of senescent astrocytes prevents Parkinson’s neuropathology and associated symptoms in a mouse model of sporadic disease, the type implicated in 95% of human cases.